Ipilimumab
本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
| CAS NO: | 477202-00-9 |
| 规格: | ≥98% |
| In vitro | Ipilimumab inhibits CTLA-4, allowing the T cell immune response to be reactivated against tumor cells. Ipilimumab can promote antitumor activity as a single agent or in combination with cytokines, chemotherapy, or vaccines. |
|---|
| In Vivo | N/A |
|---|
| Protocol |
|
|---|
| References | Expert Opin Biol Ther. 2009 Feb;9(2):231-41. |
|---|
